SWITZERLAND/JAPAN: NATURAL COSMETICS BY WELEDA

Article Abstract:

In view of the growing acceptance of natural cosmetics, the Swiss Arlesheim-based Weleda group is to focus increasingly on international markets. The company's new face care line is said to have aroused great interest in Japan. In 1999 Weleda's turnover from cosmetics increased 12%, while the sales of pharmaceuticals grew 1%, in line with the development of the market. Germany, France and Switzerland (SFr 24.9mn) made the biggest contributions to Weleda group's 1999 turnover of SFr 179.7mn, up 5.8% from 1998. Profit rose 11.4% to SFr 5.1mn. Weleda has set a specialisation course for its production plants in Arlesheim and German Schwabisch Gmund, which make cosmetics, and French Huningue, which produces pharmaceuticals.

Japan, Sales, profits & dividends, Vitamin, Nutrient & Hematinic Preps, Pharmaceutical Preparation Manufacturing, Toiletries, Toilet Preparation Manufacturing, Pharmaceutical preparations, Toilet preparations

---

Zeller verf nffacht Produktionskapazit t f rPhytopharmaka

Article Abstract:

Swiss producer of phytopharmaceuticals Zeller AG of Romanshorn invests about 15% of turnover, which amounts to about DM 20mn, into research and development. The company focuses on indication areas such as depression, sleep disorders, pre-menstrual tension, menopause and allergy. By investing SFr 70mn in the last four years, family-owned Zeller increased its production capacity fivefold. The company with 80 employees is to expand business in particular in the US. Negotiations with a US company are under way.

Comment:

Swiss producer of phytopharmaceuticals invests about 15% of turnover, which amounts to about DM20 mil, into R&D

Research & development outlays, Medicinal and Botanical Manufacturing, Bulk Medicinals & Botanicals, Article, Zeller AG

---

Similar abstracts:

• Abstracts: US/SWITZERLAND: ZELLER COOPERATES WITH SKB. US/SWITZERLAND: NOVARTIS, RIGEL R&D DEAL. US/SWITZERLAND: EMISPHERE LICENCE TO NOVARTIS
• Abstracts: SWITZERLAND: NEW POLYAMIDE BY EMS-CHEMIE. SWITZERLAND: MADER EXPAND SYNTHETIC RESIN OUTPUT. SWITZERLAND: CREANOVA CONCENTRATES DISTRIBUTION
• Abstracts: SWITZERLAND: CIBA INVESTING IN HALS. GERMANY: JOINT VENTURE FOR CONSTAB, RESINEX

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.